http://www.investor.jnj.com/medialist_podcast.cfmJohnson & Johnson Investor Relations Podcasten-usShareholder.com RSS Feedhttp://www.investor.jnj.com/eventdetail.cfm?EventID=74566Tue, 03 Nov 2009 05:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=74566Johnson & Johnson Announces Restructuring Initiatives for Sustainable Growthhttp://www.investor.jnj.com/eventdetail.cfm?EventID=73505Tue, 13 Oct 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=73505Johnson & Johnson Third Quarter 2009 Earnings Meetinghttp://www.investor.jnj.com/eventdetail.cfm?EventID=72670Tue, 15 Sep 2009 14:55:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=72670Johnson & Johnson at Morgan Stanley Global Healthcare Conferencehttp://www.investor.jnj.com/eventdetail.cfm?EventID=70849Tue, 14 Jul 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=70849Johnson & Johnson Second Quarter 2009 Earnings Conference Callhttp://www.investor.jnj.com/eventdetail.cfm?EventID=69775Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69775Johnson & Johnson Pharmaceuticals Business Review: Introduction, Opening Remarks and Overviewhttp://www.investor.jnj.com/eventdetail.cfm?EventID=69774Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69774Johnson & Johnson Pharmaceuticals Business Review: R&D Strategyhttp://www.investor.jnj.com/eventdetail.cfm?EventID=69773Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69773Johnson & Johnson Pharmaceuticals Business Review: Neurosciencehttp://www.investor.jnj.com/eventdetail.cfm?EventID=69772Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69772Johnson & Johnson Pharmaceuticals Business Review: Cardiovascular and Metabolismhttp://www.investor.jnj.com/eventdetail.cfm?EventID=69771Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69771Johnson & Johnson Pharmaceuticals Business Review: Infectious Diseasehttp://www.investor.jnj.com/eventdetail.cfm?EventID=69770Thu, 04 Jun 2009 04:00:00 GMThttp://www.investor.jnj.com/eventdetail.cfm?EventID=69770Johnson & Johnson Pharmaceuticals Business Review: Morning Q&A